Dr. Daniel Robert More, MD

Dr. More practices at Allergy Partners of California, Inc. in San Luis Obispo, California.

Dr. More's NPI, 1306844279, was assigned on July 13, 2005. Dr. More graduated from David Geffen School of Medicine at UCLA in 1998. Dr. More holds California license A72421.

Dr. More's primary practice is Allergy Partners of California, Inc., at 1551 Bishop St, San Luis Obispo, CA 93401 in San Luis Obispo County. The practice phone is (805) 543-2744.

Dr. More's primary practice is Allergy Partners of California, Inc. in San Luis Obispo, California. Dr. More is also affiliated with Dignity Health - French Hospital Medical Center. The medical group on file is Allergy Partners of California Central Coast. Dmand AI also links Dr. More to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. More practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. More's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. More is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. More is licensed in California.

Dmand AI lists asthma, chronic nasal allergies, chronic sinusitis and hives among the conditions Dr. More treats.

CMS data shows 17,009 Medicare services from Dr. More across 18 procedure codes in 2024, for 523 Medicare patients. Medicare paid $256,162 for them. Every service was in an office.

CMS counts 523 Medicare patients who saw Dr. More in 2024. The largest group is 65 to 74, with 285 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 12% are also on Medicaid. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. More's median patient age at 39, with 57% women.

In 2024, Dr. More wrote 1,383 Medicare Part D claims for 218 patients. 81% of them were for generic drugs. CMS names the drug for 1,256 of them, across 22 drugs with 11 or more claims each, at $200,122 in total drug cost. In 2023, CMS named 921 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. More for performance year 2024, reported as part of a group. Dr. More accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. More as offering telehealth.

Dmand AI links 9 papers to Dr. More. The most frequent topics are Immunoglobulin E, Skin Tests and Allergens. Dr. More's most frequent co-authors are Theodore Monroe Freeman, MD, Jeffrey S. Nugent, MD and Kevin E. O'Brien, MD.

CMS Open Payments shows 147 general payments to Dr. More from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $1,785.

Dmand AI lists 1 award for Dr. More.

Dr. More graduated from David Geffen School of Medicine at UCLA in 1998. Dr. More is a member of ACAAI, AAAAI and ACP.

Dr. More is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.